VTV Therapeutics Inc. Class AVTVT
13F holders, Q2 2025 (June 30)21holders
2new positions
3sold out
1famous investor
$14.89avg. 13F price*
At the end of Q2 2025, 21 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, unchanged from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Samsara Biocapital, LLC ($3.1M), FMR LLC ($2.6M) and Baker Bros. Advisors LP ($1.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $222K |
| Exits | 3 | $7K |
All 13F filers, Q1 2025 → Q2 2025: 17,367 shares bought and 1,944 shares sold, net +15,423 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Samsara Biocapital, LLC | 0.63% | No change | 206,784 | $3.1M |
| FMR LLC | 0.00% | No change | 178,200 | $2.6M |
| Baker Bros. Advisors LP | 0.01% | No change | 97,314 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +3.9% | 43,175 | $636K |
| Northern Trust Corp. | 0.00% | Reduce -2.2% | 15,287 | $229K |
| Millennium Management | 0.00% | New | 15,042 | $222K |
| Geode Capital Management, LLC | 0.00% | Add +1.8% | 12,866 | $190K |
| Connective Capital Management, LLC | 0.14% | Add +3.6% | 9,712 | $146K |
| BlackRock, Inc. | 0.00% | Add +2.6% | 4,827 | $72K |
| UBS Group AG | 0.00% | Reduce -29.5% | 2,847 | $43K |
| Morgan Stanley | 0.00% | No change | 746 | $11K |
| Osaic Holdings, Inc. | 0.00% | Add +11.8% | 170 | $3K |
| Activest Wealth Management | 0.00% | No change | 50 | $750 |
| CoreCap Advisors, LLC | 0.00% | No change | 45 | $675 |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $570 |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $207 |
| Bank of America Corp. | 0.00% | Add +20.0% | 12 | $180 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $135 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -80.0% | 2 | $30 |
| Raymond James Financial Inc. | 0.00% | New | 1 | $15 |
| Strategic Wealth Partners, Ltd. | 0.00% | — | 1 | $15 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.